20 of 21 Eliquis LawSuits Cut from MDL Case
A federal judge in New York has dismissed 20 of the 21 Multi-District Litigation (MDL) cases against Pfizer and Bristol-Myers Squibb over the alleged risks of its blood-thinning drug Eliquis.
Twenty-four other cases in the MDL were dismissed in June.
The central issue in the cases is whether the drugmakers adequately informed doctors and patients of the risks involved with Eliquis, a drug that plaintiffs allege can cause severe gastrointestinal bleeding.
The one remaining case against the drug manufacturers is that of Sheila Fortner, a Tennessee woman who experienced gastrointestinal bleeding upon taking Eliquis for the purpose of reducing her risk of a stroke.
The case against Eliquis has not yet been decided. If you believe that Eliquis is responsible for any gastric distress you may have experienced, you may still have a case. Contact TheLawFirm.com for a free consultation.
Lawsuit filed against eliquis manufacturer Bristol-myers squibb and pfizer
Two relatives of a man who died after taking the anticoagulant Eliquis have filed suit in New York against the drug’s manufacturers, Bristol-Myers Squibb and Pfizer, alleging that the companies inadequately tested the product for safety and concealed from the public the risks of the drug.
The suit alleges that the companies’ clinical tests of Eliquis took place in substandard conditions in Chinese labs, and that the makers of Eliquis knew about the drug’s potential hazards but knowingly concealed that information from patients and doctors.
Further, the suit alleges, the drugmakers have not made it clear to consumers that a mishap with the drug may be irreversible. Eliquis is a brand name for a drug known as apixaban. The side effects of other drugs in the apixaban family tend to be reversible.
The suit was prompted by the 2014 death of Raymond Warme, who died from gastrointestinal bleeding two months after he started taking Eliquis. In that same year, the FDA received reports of 100 deaths and more than 1000 adverse health problems that were alleged to be related to Eliquis. In 2015, a further 6000 cases of adverse health problems were reported. Most of the cases involved gastrointestinal hemorrhaging.
Eliquis remains on the market, its formula unchanged.
If you believe that your health problems have been caused by a drug that’s been improperly tested, or a drug whose dangerous side effects have been covered up, contact TheLawFirm.com. We can help you.